Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


miR-20a regulates Fas expression in osteosarcoma cells by modulating Fas promoter activity and can be therapeutically targeted to inhibit lung metastases.

Yang Y, Huang G, Zhou Z, Fewell JG, Kleinerman ES.

Mol Cancer Ther. 2017 Oct 27. pii: molcanther.0042.2017. doi: 10.1158/1535-7163.MCT-17-0042. [Epub ahead of print]


Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions.

Tak WY, Lin SM, Wang Y, Zheng J, Vecchione A, Park SY, Chen MH, Wong S, Xu R, Peng CY, Chiou YY, Huang GT, Cai J, Abdullah BJJ, Lee JS, Lee JY, Choi JY, Gopez-Cervantes J, Sherman M, Finn RS, Omata M, O'Neal M, Makris L, Borys N, Poon R, Lencioni R.

Clin Cancer Res. 2017 Oct 10. doi: 10.1158/1078-0432.CCR-16-2433. [Epub ahead of print]


Antisense MicroRNA Therapy of Airway Remodeling in House Dust Mite-sensitized Mice.

Ramelli S, McLendon JM, Ferretti AP, Fewell J, Barrington R, Gerthoffer WT.

Ann Am Thorac Soc. 2016 Mar;13 Suppl 1:S101-2. doi: 10.1513/AnnalsATS.201507-414MG. No abstract available.


Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension.

Aghamohammadzadeh R, Zhang YY, Stephens TE, Arons E, Zaman P, Polach KJ, Matar M, Yung LM, Yu PB, Bowman FP, Opotowsky AR, Waxman AB, Loscalzo J, Leopold JA, Maron BA.

FASEB J. 2016 Jul;30(7):2511-27. doi: 10.1096/fj.201500042. Epub 2016 Mar 22.


Increased Duration of Heating Boosts Local Drug Deposition during Radiofrequency Ablation in Combination with Thermally Sensitive Liposomes (ThermoDox) in a Porcine Model.

Swenson CE, Haemmerich D, Maul DH, Knox B, Ehrhart N, Reed RA.

PLoS One. 2015 Oct 2;10(10):e0139752. doi: 10.1371/journal.pone.0139752. eCollection 2015.


Implications of In-Use Photostability: Proposed Guidance for Photostability Testing and Labeling to Support the Administration of Photosensitive Pharmaceutical Products, Part 2: Topical Drug Product.

Baertschi SW, Clapham D, Foti C, Kleinman MH, Kristensen S, Reed RA, Templeton AC, T√łnnesen HH.

J Pharm Sci. 2015 Sep;104(9):2688-701. doi: 10.1002/jps.24396. Epub 2015 Feb 24. Review.


Supplemental Content

Loading ...
Support Center